Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 346.76 Million USD | -29.08% |
| 2022 | 488.92 Million USD | -2.49% |
| 2021 | 501.38 Million USD | 88.14% |
| 2020 | 266.49 Million USD | -7.59% |
| 2019 | 288.38 Million USD | 4893.66% |
| 2018 | 5.77 Million USD | -92.62% |
| 2017 | 78.2 Million USD | -10.94% |
| 2016 | 87.8 Million USD | -7.57% |
| 2015 | 95 Million USD | -8.98% |
| 2014 | 104.37 Million USD | 216.28% |
| 2013 | 33 Million USD | -50.68% |
| 2012 | 66.9 Million USD | -40.02% |
| 2011 | 111.55 Million USD | -22.9% |
| 2010 | 144.68 Million USD | -15.34% |
| 2009 | 170.89 Million USD | -40.23% |
| 2008 | 285.94 Million USD | 2101.08% |
| 2007 | 12.99 Million USD | 514.52% |
| 2006 | 2.11 Million USD | -95.09% |
| 2005 | 43.06 Million USD | 2419.78% |
| 2004 | 1.7 Million USD | -44.64% |
| 2003 | 3.08 Million USD | -44.04% |
| 2002 | 5.51 Million USD | -37.31% |
| 2001 | 8.79 Million USD | -6.12% |
| 2000 | 9.37 Million USD | 287.79% |
| 1999 | 2.41 Million USD | -55.63% |
| 1998 | 5.44 Million USD | 74.08% |
| 1997 | 3.12 Million USD | 37.27% |
| 1996 | 2.27 Million USD | 51.96% |
| 1995 | 1.5 Million USD | 200.0% |
| 1994 | 500 Thousand USD | 150.0% |
| 1993 | 200 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 351.44 Million USD | -1.3% |
| 2024 Q1 | 356.08 Million USD | 2.69% |
| 2023 Q1 | 433.02 Million USD | -11.43% |
| 2023 Q3 | 428.73 Million USD | -0.19% |
| 2023 Q2 | 429.53 Million USD | -0.81% |
| 2023 Q4 | 346.76 Million USD | -19.12% |
| 2023 FY | 346.76 Million USD | -29.08% |
| 2022 Q3 | 515.46 Million USD | 0.08% |
| 2022 FY | 488.92 Million USD | -2.49% |
| 2022 Q1 | 499.74 Million USD | -0.33% |
| 2022 Q2 | 515.03 Million USD | 3.06% |
| 2022 Q4 | 488.92 Million USD | -5.15% |
| 2021 Q2 | 242.56 Million USD | -17.7% |
| 2021 Q3 | 502.5 Million USD | 107.16% |
| 2021 FY | 501.38 Million USD | 88.14% |
| 2021 Q1 | 294.73 Million USD | 10.6% |
| 2021 Q4 | 501.38 Million USD | -0.22% |
| 2020 Q2 | 454.32 Million USD | 4.47% |
| 2020 Q4 | 266.49 Million USD | -26.6% |
| 2020 Q3 | 363.09 Million USD | -20.08% |
| 2020 Q1 | 434.86 Million USD | 50.79% |
| 2020 FY | 266.49 Million USD | -7.59% |
| 2019 Q1 | 359.57 Million USD | 6126.37% |
| 2019 FY | 288.38 Million USD | 4893.66% |
| 2019 Q4 | 288.38 Million USD | 0.04% |
| 2019 Q2 | 323.86 Million USD | -9.93% |
| 2019 Q3 | 288.26 Million USD | -10.99% |
| 2018 Q2 | 123.93 Million USD | 63.54% |
| 2018 Q3 | 54.85 Million USD | -55.74% |
| 2018 Q4 | 5.77 Million USD | -89.47% |
| 2018 Q1 | 75.78 Million USD | -3.1% |
| 2018 FY | 5.77 Million USD | -92.62% |
| 2017 Q2 | 83.15 Million USD | -2.71% |
| 2017 Q3 | 80.52 Million USD | -3.17% |
| 2017 Q4 | 78.2 Million USD | -2.88% |
| 2017 Q1 | 85.47 Million USD | -2.66% |
| 2017 FY | 78.2 Million USD | -10.94% |
| 2016 FY | 87.8 Million USD | -7.57% |
| 2016 Q3 | 88.87 Million USD | -0.7% |
| 2016 Q4 | 87.8 Million USD | -1.2% |
| 2016 Q1 | 90.56 Million USD | -4.67% |
| 2016 Q2 | 89.5 Million USD | -1.18% |
| 2015 Q2 | 83.51 Million USD | -3.39% |
| 2015 Q1 | 86.44 Million USD | -17.18% |
| 2015 FY | 95 Million USD | -8.98% |
| 2015 Q4 | 95 Million USD | -1.3% |
| 2015 Q3 | 96.25 Million USD | 15.25% |
| 2014 Q2 | 132 Million USD | 340.0% |
| 2014 Q4 | 104.37 Million USD | 2.03% |
| 2014 FY | 104.37 Million USD | 216.28% |
| 2014 Q1 | 30 Million USD | -9.09% |
| 2014 Q3 | 102.29 Million USD | -22.5% |
| 2013 Q3 | 36 Million USD | -7.69% |
| 2013 FY | 33 Million USD | -50.68% |
| 2013 Q2 | 39 Million USD | -9.2% |
| 2013 Q4 | 33 Million USD | -8.33% |
| 2013 Q1 | 42.95 Million USD | -35.8% |
| 2012 Q4 | 66.9 Million USD | -7.45% |
| 2012 Q1 | 68.37 Million USD | -38.7% |
| 2012 Q2 | 67.7 Million USD | -0.99% |
| 2012 Q3 | 72.28 Million USD | 6.77% |
| 2012 FY | 66.9 Million USD | -40.02% |
| 2011 Q1 | 136.13 Million USD | -5.91% |
| 2011 FY | 111.55 Million USD | -22.9% |
| 2011 Q2 | 127.9 Million USD | -6.05% |
| 2011 Q3 | 119.72 Million USD | -6.39% |
| 2011 Q4 | 111.55 Million USD | -6.83% |
| 2010 FY | 144.68 Million USD | -15.34% |
| 2010 Q1 | 162.79 Million USD | -4.74% |
| 2010 Q2 | 162.34 Million USD | -0.28% |
| 2010 Q4 | 144.68 Million USD | -9.78% |
| 2010 Q3 | 160.37 Million USD | -1.21% |
| 2009 Q2 | 196.9 Million USD | -26.64% |
| 2009 Q4 | 170.89 Million USD | -4.76% |
| 2009 Q3 | 179.44 Million USD | -8.87% |
| 2009 Q1 | 268.4 Million USD | -6.13% |
| 2009 FY | 170.89 Million USD | -40.23% |
| 2008 FY | 285.94 Million USD | 2101.08% |
| 2008 Q1 | 375.93 Million USD | 2793.79% |
| 2008 Q2 | 336.45 Million USD | -10.5% |
| 2008 Q3 | 316.01 Million USD | -6.08% |
| 2008 Q4 | 285.94 Million USD | -9.52% |
| 2007 Q2 | 8.06 Million USD | 215.62% |
| 2007 FY | 12.99 Million USD | 514.52% |
| 2007 Q3 | 13.32 Million USD | 65.24% |
| 2007 Q1 | 2.55 Million USD | 20.86% |
| 2007 Q4 | 12.99 Million USD | -2.51% |
| 2006 Q1 | 41.15 Million USD | -4.44% |
| 2006 FY | 2.11 Million USD | -95.09% |
| 2006 Q2 | 39.21 Million USD | -4.7% |
| 2006 Q3 | 36.51 Million USD | -6.89% |
| 2006 Q4 | 2.11 Million USD | -94.21% |
| 2005 Q3 | 55.2 Million USD | 2541.53% |
| 2005 FY | 43.06 Million USD | 2419.78% |
| 2005 Q4 | 43.06 Million USD | -22.0% |
| 2005 Q2 | 2.09 Million USD | -7.32% |
| 2005 Q1 | 2.25 Million USD | 31.95% |
| 2004 Q1 | 2.19 Million USD | -28.8% |
| 2004 FY | 1.7 Million USD | -44.64% |
| 2004 Q4 | 1.7 Million USD | -16.96% |
| 2004 Q3 | 2.05 Million USD | 46.27% |
| 2004 Q2 | 1.4 Million USD | -35.99% |
| 2003 Q2 | 3.21 Million USD | -23.65% |
| 2003 Q1 | 4.2 Million USD | -23.71% |
| 2003 Q4 | 3.08 Million USD | -4.28% |
| 2003 FY | 3.08 Million USD | -44.04% |
| 2003 Q3 | 3.22 Million USD | 0.37% |
| 2002 Q4 | 5.51 Million USD | -20.36% |
| 2002 Q2 | 8.14 Million USD | 18.55% |
| 2002 Q1 | 6.86 Million USD | -21.95% |
| 2002 FY | 5.51 Million USD | -37.31% |
| 2002 Q3 | 6.92 Million USD | -14.93% |
| 2001 Q3 | 5 Million USD | -31.29% |
| 2001 FY | 8.79 Million USD | -6.12% |
| 2001 Q2 | 7.28 Million USD | -22.53% |
| 2001 Q1 | 9.39 Million USD | 0.26% |
| 2001 Q4 | 8.79 Million USD | 75.91% |
| 2000 FY | 9.37 Million USD | 287.79% |
| 2000 Q2 | 17.18 Million USD | 467.19% |
| 2000 Q4 | 9.37 Million USD | -38.04% |
| 2000 Q3 | 15.12 Million USD | -11.98% |
| 2000 Q1 | 3.03 Million USD | 26.25% |
| 1999 Q1 | 5.8 Million USD | 6.48% |
| 1999 Q4 | 2.4 Million USD | -87.69% |
| 1999 Q3 | 19.5 Million USD | 254.55% |
| 1999 FY | 2.41 Million USD | -55.63% |
| 1999 Q2 | 5.5 Million USD | -5.17% |
| 1998 FY | 5.44 Million USD | 74.08% |
| 1998 Q3 | 5 Million USD | 2.04% |
| 1998 Q4 | 5.44 Million USD | 8.94% |
| 1998 Q1 | 3.6 Million USD | 15.05% |
| 1998 Q2 | 4.9 Million USD | 36.11% |
| 1997 Q3 | 3.3 Million USD | -5.71% |
| 1997 Q2 | 3.5 Million USD | 0.0% |
| 1997 FY | 3.12 Million USD | 37.27% |
| 1997 Q1 | 3.5 Million USD | 53.55% |
| 1997 Q4 | 3.12 Million USD | -5.18% |
| 1996 Q2 | 1.9 Million USD | 11.76% |
| 1996 Q3 | 2.1 Million USD | 10.53% |
| 1996 FY | 2.27 Million USD | 51.96% |
| 1996 Q1 | 1.7 Million USD | 13.33% |
| 1996 Q4 | 2.27 Million USD | 8.55% |
| 1995 FY | 1.5 Million USD | 200.0% |
| 1995 Q2 | 1.7 Million USD | 183.33% |
| 1995 Q1 | 600 Thousand USD | 20.0% |
| 1995 Q3 | 1.8 Million USD | 5.88% |
| 1995 Q4 | 1.5 Million USD | -16.67% |
| 1994 FY | 500 Thousand USD | 150.0% |
| 1994 Q4 | 500 Thousand USD | 0.0% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q1 | 200 Thousand USD | 0.0% |
| 1993 FY | 200 Thousand USD | 0.0% |
| 1993 Q4 | 200 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 74.171% |
| Addus HomeCare Corporation | 124.13 Million USD | -179.349% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -398.917% |
| American Oncology Network, Inc. | 120.44 Million USD | -187.903% |
| Astrana Health, Inc. | 296.26 Million USD | -17.046% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 72.832% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -225.201% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -3635.864% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -12921.48% |
| COMPASS Pathways plc | 28.75 Million USD | -1105.835% |
| DocGo Inc. | 15.16 Million USD | -2187.059% |
| The Ensign Group, Inc. | 1.78 Billion USD | 80.572% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -2986.444% |
| InnovAge Holding Corp. | 100.49 Million USD | -245.051% |
| Assure Holdings Corp. | 505 Thousand USD | -68565.743% |
| The Joint Corp. | 2 Million USD | -17238.1% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -23.718% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -90808.9% |
| ModivCare Inc. | 983.75 Million USD | 64.751% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -291348.071% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -19617.903% |
| Option Care Health, Inc. | 1.05 Billion USD | 67.183% |
| P3 Health Partners Inc. | 108.31 Million USD | -220.13% |
| P3 Health Partners Inc. | 108.31 Million USD | -220.13% |
| The Pennant Group, Inc. | 312.51 Million USD | -10.96% |
| Surgery Partners, Inc. | 2.03 Billion USD | 82.948% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -299.376% |
| The Oncology Institute, Inc. | 86.82 Million USD | -299.376% |